TRANSLATING SCIENCE INTO MEDICINES...!

Phenex Pharmaceuticals AG is a drug discovery and development company, focused on small-molecule therapeutics.

Latest News

Phenex collaborates with Mathias Heikenwälder ́s research group from DKFZ (German Cancer Research Center)
[2019-04-05]
Phenex kooperiert mit Mathias Heikenwälders Forschungsgruppe am DKFZ (Deutsches Krebsforschungszentrum)
[2019-04-05]

Upcoming Events - Meet us




Recent Poster Presentations

Targeting the IDO1-Kynurenine-AhR pathway for cancer immunotherapyPDF
AACR Annual Meeting 2019, March 29 - Apr 3, 2019, Atlanta, Georgia, USA
Identification of a potent, orally bioavailable and selective MCT4 inhibitor for the treatment of solid Warburg tumorsPDF
AACR Annual Meeting 2019, March 29 - Apr 3, 2019, Atlanta, Georgia, USA
Unexpected anti-diabetic effects and anti-fibrotic activities of LXR inverse agonists in mouse models of NADFLD/NASHPDF
American Association for the Study of the Liver Diseases: “The Liver Meeting™ 2018”, November 9-13, 2018 San Francisco, USA